切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2017, Vol. 11 ›› Issue (05) : 336 -339. doi: 10.3877/cma.j.issn.1674-0793.2017.05.010

所属专题: 文献

论著

乳腺癌彩色多普勒血流显像与微血管密度及乳腺癌预后的相关性研究
刘洋1, 王兴田2,()   
  1. 1. 221002 徐州,徐州医科大学附属医院超声科;222002 江苏省连云港市第一人民医院超声科
    2. 221002 徐州,徐州医科大学附属医院超声科
  • 收稿日期:2017-07-08 出版日期:2017-10-01
  • 通信作者: 王兴田

Correlation between color doppler flow imaging and microvessel density, and the Nottingham prognostic index in breast cancer patients

Yang Liu1, Xingtian Wang2,()   

  1. 1. Department of Ultrasonography, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China; Department of Ultrasonography, the First People’s Hospital of Lianyungang, Lianyungang 222002, China
    2. Department of Ultrasonography, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China
  • Received:2017-07-08 Published:2017-10-01
  • Corresponding author: Xingtian Wang
  • About author:
    Corresponding author: Wang Xingtian, Email:
引用本文:

刘洋, 王兴田. 乳腺癌彩色多普勒血流显像与微血管密度及乳腺癌预后的相关性研究[J]. 中华普通外科学文献(电子版), 2017, 11(05): 336-339.

Yang Liu, Xingtian Wang. Correlation between color doppler flow imaging and microvessel density, and the Nottingham prognostic index in breast cancer patients[J]. Chinese Archives of General Surgery(Electronic Edition), 2017, 11(05): 336-339.

目的

探讨乳腺癌彩色多普勒超声(CDFI)与微血管密度(MVD)及诺丁汉预后指数(NPI)的相关性。

方法

回顾性分析2011年9至2013年12月连云港市第一人民医院100例乳腺浸润性导管癌患者,采用CDFI检测乳腺癌血流信号,血流信号强度按照ADLER分为0~3级。免疫组化方法检测MVD评价乳腺癌的血管生成情况。术后病理评估肿瘤大小、淋巴结状态及组织学分级,诺丁汉预后指数(NPI)=病灶最大径(cm)×0.2 +淋巴结分期(1~3)+组织学分级(1~3)。根据NPI评分(<3.4、3.4~5.4、>5.4)分为三个等级。统计分析CDFI分级和MVD及NPI的相关性。

结果

方差分析发现CDFI不同分级之间MVD数值差异有统计学意义(F=26.997,P<0.001);秩相关检验结果表明CDFI分级和NPI之间存在相关性(r=0.555,P<0.001)。随着CDFI逐级升高,MVD数目及NPI值逐渐增加。

结论

CDFI与MVD及NPI显著相关,能够初步判断乳腺癌患者预后。

Objective

To investigate the correlation between color doppler flow imaging (CDFI) and microvessel density (MVD), and the Nottingham prognostic index (NPI) in breast cancer patients.

Methods

One hundred patients with breast carcinoma, who had undergone CDFI and surgery, were involved in this retrospective study from September 2011 to December 2013 in the First Peoples’ Hospital of Lianyungang. CDFI was divided into 4 levels: absent (grade 0), minimal (grade 1), moderate (grade 2), and marked (grade 3). The MVD was measured by immunohistochemical staining of their formalin-fixed paraffin-embedded tissue with monocloal antibody CD34. NPI was calculated as: NPI= 0.2×tumor size (cm) + grade (Ⅰ-Ⅲ) + lymph node score (1-3).

Results

Blood signal grades were positively correlated with MVD (F=26.997, P<0.001) and NPI (Spearman r=0.555, P<0.001). With the increasing of CDFI, the number of MVD and value of NPI increased gradually.

Conclusion

CDFI may be useful as a prognostic indicator for patients with breast carcinoma.

图1 CDFI分级(A,0级;B,1级;C,2级;D,3级)
图2 CD34阳性染色(免疫组织化学染色SP法,箭头示棕色血管×200)
[1]
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015 [J]. CA Cancer J Clin, 2015, 65(1):5-29.
[2]
Shen ZY, Hu B, Wu MF. Correlation between blood flow signal of color flow imaging and Nottingham prognostic index in patients with breast carcinoma [J]. Breast Care, 2012, 7(2):126-130.
[3]
Uzzan B, Nicolas P, Cucherat M, et al. Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis[J]. Cancer Res, 2004, 64(9):2941-2955.
[4]
吕宝军,殷恒讳,曾庆安, 等. EpoR在浸润性乳腺癌中的表达及与细胞增殖和微血管密度的关系[J/CD]. 中华普通外科学文献(电子版), 2010, 4(5):428-431.
[5]
Kwatra A, Aggarwal D, Gupta R, et al. Correlation of various histopathologic prognostic factors with Nottingham prognostic index and microvessel density in invasive breast carcinoma: a study of 100 cases[J]. Indian J Cancer, 2015, 52(1):110-113.
[6]
Van Belle V, Van Calster B, Brouckaert O, et al. Qualitative assessment of the progesterone receptor and HER2 improves the Nottingham Prognostic Index up to 5 years after breast cancer diagnosis[J]. J Clin Oncol, 2010, 28(27):4129-4134.
[7]
Adler DD, Carson PL, Rubin JM, et al. Doppler ultrasound color flow imaging in the study of breast cancer: preliminary findings[J]. Ultrasound Med Biol, 1990, 16(6):553-559.
[8]
Weidner N. Intratumor microvessel density as a prognostic factor in cancer[J]. Am J Pathol, 1995, 147(1):9-19.
[9]
Galea MH, Blamey RW, Elston CE, et al. The Nottingham Prognostic Index in primary breast cancer[J]. Breast Cancer Res Treat, 1992, 22(3):207-219.
[10]
Fuksa L, Micuda S, Grim J, et al. Predictive biomarkers in breast cancer: their value in neoadjuvant chemotherapy[J]. Cancer Invest, 2012, 30(9):663-678.
[11]
龚凤球,陈小俊,姚典业,等. 乳腺癌患者对乳房重建手术认同度及其相关因素的调查研究[J/CD]. 中华普通外科学文献(电子版), 2017, 11(3):213-216.
[12]
Wang Y, Dan HJ, Fan JH, et al. Evaluation of the correlation between colour power Doppler flow imaging and vascular endothelial growth factor in breast cancer [J]. J Int Med Res, 2010, 38(3):1077-1083.
[1] 郏亚平, 曾书娥. 含鳞状细胞癌成分的乳腺化生性癌的超声与病理特征分析[J]. 中华医学超声杂志(电子版), 2023, 20(08): 844-848.
[2] 唐玮, 何融泉, 黄素宁. 深度学习在乳腺癌影像诊疗和预后预测中的应用[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 323-328.
[3] 康夏, 田浩, 钱进, 高源, 缪洪明, 齐晓伟. 骨织素抑制破骨细胞分化改善肿瘤骨转移中骨溶解的机制研究[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 329-339.
[4] 衣晓丽, 胡沙沙, 张彦. HER-2低表达对乳腺癌新辅助治疗疗效及预后的影响[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 340-346.
[5] 施杰, 李云涛, 高海燕. 腋窝淋巴结阳性Luminal A型乳腺癌患者新辅助与辅助化疗的预后及影响因素分析[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 353-361.
[6] 伍秋苑, 陈佩贤, 邓裕华, 何添成, 周丹. 肠道微生物在乳腺癌中的研究进展[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 362-365.
[7] 谭巧, 苏小涵, 侯令密, 黎君彦, 邓世山. 乳腺髓样癌的诊治进展[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 366-368.
[8] 周婉丽, 钱铮, 李喆. 槐耳在乳腺癌免疫治疗中的研究进展[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 369-371.
[9] 熊倩, 罗凤. 乳腺癌患者术后康复现状与对策的研究进展[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 372-374.
[10] 杨小菁, 姜瑞瑞, 石玉香, 王静静, 李长天. 乳腺孤立性纤维性肿瘤一例[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 375-377.
[11] 冯雪园, 韩萌萌, 马宁. 乳腺原发上皮样血管内皮瘤一例[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 378-380.
[12] 康一坤, 袁芃. 三阴性乳腺癌分子遗传学及临床特征研究进展[J]. 中华乳腺病杂志(电子版), 2023, 17(05): 290-293.
[13] 王雪菲, 海琳悦, 李立方, 肖春花. Luminal A型乳腺癌的内分泌治疗与化疗[J]. 中华乳腺病杂志(电子版), 2023, 17(05): 294-300.
[14] 晏晴艳, 雍晓梅, 罗洪, 杜敏. 成都地区老年转移性乳腺癌的预后及生存因素研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 636-638.
[15] 李智铭, 郭晨明, 庄晓晨, 候雪琴, 高军喜. 早期乳腺癌超声造影定性及定量指标的对比研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 639-643.
阅读次数
全文


摘要